Solara Active Pharma Sciences Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations for the quarter ended March 31, 2026.

Regulatory Compliance Submission

The pharmaceutical company filed the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 with both BSE Limited and National Stock Exchange of India Limited on April 09, 2026. The submission was made by Company Secretary and Compliance Officer Pooja Jaya Kumar (Membership No: A57415).

Registrar Confirmation

Cameo Corporate Services Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate on April 02, 2026. The certificate confirms that securities received from depository participants for dematerialisation during Q4FY26 were properly processed and confirmed to the depositories within stipulated timeframes.

Key Compliance Confirmations

The registrar's certificate validates several critical compliance aspects:

• Securities received for dematerialisation were confirmed (accepted/rejected) to depositories
• Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
• Security certificates received for dematerialisation were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners within stipulated time limits

Corporate Information

Solara Active Pharma Sciences Limited operates from its registered office at 2nd Floor, Admin Block, 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur P.O Chennai – 600 127. The company maintains its regulatory compliance through systematic quarterly reporting to ensure adherence to SEBI depositories and participants regulations.

This quarterly submission represents part of the company's ongoing regulatory compliance framework, ensuring transparency and proper governance in securities handling and depository operations.

Solara Active Pharma Sciences Limited has published newspaper advertisements regarding the Second and Final Call Money Notice to holders of partly paid-up rights equity shares, following the earlier dispatch of notices to eligible shareholders. The company announced this development through regulatory filings on April 08, 2026.

Newspaper Publication Details

The pharmaceutical company published advertisements in leading newspapers on April 08, 2026, to inform shareholders about the circulation of the Second and Final Call Notice. The advertisements appeared in Business Standard and Pratahkal, providing wider visibility to the call money requirements.

Call Money Payment Requirements

Shareholders holding partly paid rights equity shares must pay ₹112.50 per share during the specified payment period. This amount comprises ₹3.00 towards face value and ₹109.50 towards securities premium, representing the final payment required to convert partly paid shares to fully paid equity shares.

Notice Dispatch Timeline

The company had earlier dispatched electronic notices on April 06, 2026, to shareholders whose email addresses are registered with the company, registrar Cameo Corporate Services Limited, or depository participants. Physical copies were dispatched on April 07, 2026, to shareholders without registered email addresses, with the record date set as April 02, 2026.

Payment Methods and Support

Multiple payment options are available to facilitate the call money payment process, including online ASBA through Self-Certified Syndicate Banks websites, physical ASBA by submitting application forms to designated SCSB branches, and 3-in-1 accounts using linked online trading-demat-bank accounts offered by brokers.

For queries and clarifications, shareholders can contact the registrar at +91 044 40020700/764/785/712 during business hours or email rights@cameoindia.com . The detailed instructions and ASBA application forms are available on the company's website and the registrar's portal at https://rights.cameoindia.com/solarsecondcall .